Activated platelet phospholipid membranes (PS-exposed membranes)

Activated platelet phospholipid membranes are specialized surfaces that emerge during platelet activation, characterized by the flip-flop of negatively charged phospholipids, specifically phosphatidylserine (PS), from the inner to the outer membrane leaflet (Zwaal & Schroit, 1997). This process, mediated by scramblases and the inhibition of translocases, creates a procoagulant surface essential for blood clotting (Heemskerk et al., 2013). These anionic membranes serve as a critical scaffold for the assembly of vitamin K-dependent coagulation factors, including the tenase and prothrombinase complexes, which accelerate thrombin generation by several orders of magnitude (Lentz, 2003). In pathological states, excessive or inappropriate exposure of these membranes contributes to arterial and venous thrombosis, leading to conditions such as myocardial infarction and stroke (StatPearls, 2023). Therapeutic interventions, such as Annexin V or its derivatives like Diannexin, aim to bind and mask these surfaces to prevent the assembly of clotting factors and reduce thrombotic risk (Kuypers et al., 2007). By targeting the membrane surface rather than individual enzymes, these agents offer a unique approach to modulating the coagulation cascade.

Other names

Procoagulant platelet surfacePhosphatidylserine-exposed membranesActivated platelet surfaceAnionic phospholipid membranesProcoagulant platelet membranes

Drugs targeting these membranes typically bind to exposed phosphatidylserine or phosphatidylethanolamine, sterically hindering the assembly of the tenase and prothrombinase complexes and thereby inhibiting the amplification phase of the coagulation cascade (Lentz, 2003; Kuypers et al., 2007).